A recent drug trial administered to a handful of cancer patients had the >surprising result of eliminating the disease in every participant--
involved.
The study was conducted on 18 rectal cancer patients at Memorial Sloan >Kettering Cancer Center in Manhattan and had a 100 percent success rate, >according to a paper published Sunday in the New England Journal of
Medicine.
“I believe this is the first time this has happened in the history of >cancer,” Dr. Luis A. Diaz Jr, the author of the paper, told the New York >Times.
The drug, dostarlimab, was administered to each patient every 3 weeks for
6 months.
The drug trial was expected to be followed by chemotherapy and surgery, as
is standard, for every participant.
Some patients may have even required surgery leading to bowel and urinary >dysfunction — or be forced to use a colostomy bag due to treatment, the
Times said.
However, since all patients had no evidence of a tumor after taking an
MRI, rectal examination or a biopsy they were spared the agony of
potentially damaging treatment.
“There were a lot of happy tears,” Dr. Andrea Cercek, an oncologist at >Memorial Sloan Kettering Cancer Center told the Times.
In addition to not needing further treatment, there were no instances of a >recurrence of cancer in the patients during follow-up appointments from 6
to 25 months after the trial ended.
One participant, Sascha Roth, told the Times that she planned to move to >Manhattan for chemotherapy and radiation treatment.
Then doctors gave her the good news — the trial worked and she was cancer- >free.
“I told my family,” Roth said. “They didn’t believe me.”
https://nypost.com/2022/06/06/every-cancer-patient-enters-remission-after- >drug-trial/
Sysop: | Keyop |
---|---|
Location: | Huddersfield, West Yorkshire, UK |
Users: | 546 |
Nodes: | 16 (2 / 14) |
Uptime: | 02:48:37 |
Calls: | 10,387 |
Calls today: | 2 |
Files: | 14,061 |
Messages: | 6,416,755 |